Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Center (CNIO), Madrid, E-28029, Spain.
Breast Cancer Res. 2009;11(6):R86. doi: 10.1186/bcr2456. Epub 2009 Dec 8.
Breast cancer subtypes exhibit different genomic aberration patterns with a tendency for high-level amplifications in distinct chromosomal regions. These genomic aberrations may drive carcinogenesis through the upregulation of proto-oncogenes. We have characterized DNA amplification at the human chromosomal region 13q34 in breast cancer.
A set of 414 familial and sporadic breast cancer cases was studied for amplification at region 13q34 by fluorescence in situ hybridization (FISH) analysis on tissue microarrays. Defining the minimal common region of amplification in those cases with amplification at 13q34 was carried out using an array-based comparative genomic hybridization platform. We performed a quantitative real-time - polymerase chain reaction (qRT-PCR) gene expression analysis of 11 candidate genes located within the minimal common region of amplification. Protein expression levels of two of these genes (TFDP1 and CUL4A) were assessed by immunohistochemical assays on the same tissue microarrays used for FISH studies, and correlated with the expression of a panel of 33 antibodies previously analyzed.
We have found 13q34 amplification in 4.5% of breast cancer samples, but the frequency increased to 8.1% in BRCA1-associated tumors and to 20% in basal-like tumors. Tumors with 13q34 amplification were associated with high grade, estrogen receptor negativity, and expression of EGFR, CCNE, CK5, and P-Cadherin, among other basal cell markers. We have defined a 1.83 megabases minimal common region of genomic amplification and carried out mRNA expression analyses of candidate genes located therein, identifying CUL4A and TFDP1 as the most likely target genes. Moreover, we have confirmed that tumors with 13q34 amplification significantly overexpress CUL4A and TFDP1 proteins. Tumors overexpressing either CUL4A or TFDP1 were associated with tumor proliferation and cell cycle progression markers.
We conclude that 13q34 amplification may be of relevance in tumor progression of basal-like breast cancers by inducing overexpression of CUL4A and TFDP1, which are both important in cell cycle regulation. Alternatively, as these genes were also overexpressed in non-basal-like tumor samples, they could play a wider role in cancer development by inducing tumor proliferation.
乳腺癌亚型表现出不同的基因组畸变模式,在特定染色体区域存在高水平扩增的趋势。这些基因组畸变可能通过上调原癌基因驱动致癌作用。我们已经对乳腺癌中人类染色体 13q34 区域的 DNA 扩增进行了特征描述。
通过组织微阵列上的荧光原位杂交(FISH)分析,研究了一组 414 例家族性和散发性乳腺癌病例在 13q34 区域的扩增情况。对于在 13q34 区域有扩增的那些病例,使用基于阵列的比较基因组杂交平台确定最小共同扩增区域。我们对位于最小共同扩增区域内的 11 个候选基因进行了定量实时聚合酶链反应(qRT-PCR)基因表达分析。使用用于 FISH 研究的相同组织微阵列,通过免疫组织化学测定评估了这两个基因(TFDP1 和 CUL4A)中的两个基因的蛋白表达水平,并与先前分析的 33 种抗体的表达进行了相关性。
我们发现 4.5%的乳腺癌样本中存在 13q34 扩增,但在 BRCA1 相关肿瘤中频率增加到 8.1%,在基底样肿瘤中增加到 20%。13q34 扩增的肿瘤与高级别、雌激素受体阴性以及 EGFR、CCNE、CK5 和 P-钙粘蛋白的表达有关,这是其他基底细胞标志物之一。我们已经确定了一个 1.83 兆碱基的最小共同基因组扩增区域,并对位于其中的候选基因进行了 mRNA 表达分析,确定 CUL4A 和 TFDP1 是最可能的靶基因。此外,我们已经证实,13q34 扩增的肿瘤显著过表达 CUL4A 和 TFDP1 蛋白。过表达 CUL4A 或 TFDP1 的肿瘤与肿瘤增殖和细胞周期进展标志物相关。
我们得出结论,13q34 扩增可能通过诱导 CUL4A 和 TFDP1 的过度表达在基底样乳腺癌的肿瘤进展中具有相关性,这两者在细胞周期调节中都很重要。或者,由于这些基因在非基底样肿瘤样本中也过度表达,它们可能通过诱导肿瘤增殖在癌症发展中发挥更广泛的作用。